Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,880 | 82 | 96.9% |
| Education | $60.99 | 2 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $322.93 | 16 | $0 (2024) |
| ITI, Inc. | $225.70 | 11 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $209.97 | 9 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $187.96 | 9 | $0 (2024) |
| Bausch Health US, LLC | $187.41 | 8 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $150.07 | 7 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $142.72 | 5 | $0 (2024) |
| Lundbeck LLC | $131.32 | 4 | $0 (2023) |
| Supernus Pharmaceuticals, Inc. | $83.56 | 4 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $79.82 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $864.86 | 39 | ABBVIE INC. ($236.07) |
| 2023 | $663.85 | 28 | Lundbeck LLC ($98.71) |
| 2022 | $412.06 | 17 | ITI, Inc. ($128.35) |
All Payment Transactions
84 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: PSYCHIATRY | ||||||
| 12/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $29.19 | General |
| Category: Neuropsychiatry | ||||||
| 10/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $31.20 | General |
| Category: PSYCHIATRY | ||||||
| 09/27/2024 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $14.86 | General |
| Category: ADHD | ||||||
| 09/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: Neuropsychiatry | ||||||
| 09/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: PSYCHIATRY | ||||||
| 09/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: NEUROSCIENCE | ||||||
| 08/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $30.69 | General |
| Category: PSYCHIATRY | ||||||
| 08/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: PSYCHIATRY | ||||||
| 06/22/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $28.03 | General |
| Category: CNS | ||||||
| 06/10/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 06/07/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MYCITE (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: PSYCHIATRY | ||||||
| 05/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.76 | General |
| Category: PSYCHIATRY | ||||||
| 05/29/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $34.22 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 05/24/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $29.52 | General |
| Category: SCHIZOPHRENIA | ||||||
| 05/20/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $27.50 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 1 | 17 | 42 | $12,202 | $4,476 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 42 | $12,202 | $4,476 | 36.7% |
About Jonathan Love
Jonathan Love is a Psychiatry healthcare provider based in Quincy, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2017. The National Provider Identifier (NPI) number assigned to this provider is 1790212041.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jonathan Love has received a total of $1,941 in payments from pharmaceutical and medical device companies, with $864.86 received in 2024. These payments were reported across 84 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,880).
As a Medicare-enrolled provider, Love has provided services to 17 Medicare beneficiaries, totaling 42 services with total Medicare billing of $4,476. Data is available for 1 year (2021–2021), covering 1 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Quincy, MA
- Active Since 05/17/2017
- Last Updated 08/13/2021
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1790212041
Products in Payments
- CAPLYTA (Drug) $413.66
- VRAYLAR (Drug) $322.93
- APLENZIN (Drug) $187.41
- REXULTI (Drug) $176.29
- TRINTELLIX (Drug) $150.07
- ABILIFY MYCITE (Drug) $119.20
- HETLIOZ (Drug) $113.20
- INGREZZA (Drug) $79.82
- SPRAVATO (Drug) $73.72
- Qelbree (Drug) $41.84
- QELBREE (Drug) $41.72
- FANAPT (Drug) $29.52
- ARISTADA (Drug) $28.03
- ABILIFY ASIMTUFII (Drug) $27.32
- LYBALVI (Drug) $26.55
- ZURZUVAE (Drug) $19.79
- ABILIFY MAINTENA (Drug) $18.48
- Adzenys XR-ODT (Drug) $14.86
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Quincy
Dr. Alexandra Accardi, Md, MD
Psychiatry — Payments: $3,546
Salvador Sanchez-Zuniga, Md, MD
Psychiatry — Payments: $2,464
Lani Nicholson, M.d, M.D
Psychiatry — Payments: $957.79
Richard Reiner, M.d, M.D
Psychiatry — Payments: $707.55
Scott Wright, M.d, M.D
Psychiatry — Payments: $705.10
Dr. Stephen Dubin, Do, DO
Psychiatry — Payments: $496.90